DIA
SAGE

Dana Investment Advisors’s Sage Therapeutics SAGE Stock Holding History

Dana Investment Advisors’s Portfolio SAGE Stock Details SAGE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-14,205
Closed -$807K – 328
2021
Q2 		$807K Buy
14,205
+3,033
+27% +$214K 0.04% 218
2021
Q1 		$836K Buy
+11,172
New +$916K 0.04% 220

Other funds holding SAGE

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return

Dana Investment Advisors's SAGE Position: Q3 2021 in Review

Dana Investment Advisors sold out of Sage Therapeutics (SAGE) in Q3 2021, closing a stake of 14,205 shares — an estimated $807K sold.

Dana Investment Advisors first reported a position in SAGE in Q1 2021 and held it in 2 quarters. The position peaked at $836K in Q1 2021. 225 funds tracked by Wall St. Rank hold SAGE as of Q3 2021.

  • Dana Investment Advisors reported no remaining Sage Therapeutics position as of Q3 2021 after selling out during the quarter.
  • Dana Investment Advisors sold 14,205 Sage Therapeutics shares in Q3 2021, an estimated $807K.
  • Dana Investment Advisors first reported a position in Sage Therapeutics in Q1 2021 and held it in 2 quarters.
  • Dana Investment Advisors's Sage Therapeutics position peaked at $836K in Q1 2021.
  • 225 funds tracked by Wall St. Rank held Sage Therapeutics as of Q3 2021.

Based on Dana Investment Advisors's 13F filing for Q3 2021, filed 12 Nov 2021.